Patients with previously treated metastatic pancreatic cancer who took an oral once-daily pill called daraxonrasib lived ...

LUND, SE / ACCESS Newswire / June 26, 2026 / Cantargia AB (publ) (STO:CANTA) today announced the publication of preclinical ...

Blood drawn from pancreatic cancer patients within weeks of starting chemotherapy can separate those likely to survive ...

The annual Prospectors & Developers Association of Canada (PDAC) convention is returning this year from March 3 to 6, and it comes as countries around the world take steps to secure supply of key ...

Verastem, Inc. kept at Buy on KRAS G12D catalysts and strong PDAC data; read TARGET-D 101 & VS-7375 updates plus cash runway ...

Purple Biotech (PPBT Quick Quote PPBT - Free Report) , a clinical-stage oncology company, reported positive final results from the mid-stage study of its lead candidate, CM24, for treating pancreatic ...

Pancreatic ductal adenocarcinoma (PDAC) is the most common form of pancreatic cancer. It's also one of the deadliest. More than 90% of PDAC patients die within five years of diagnosis. Usually, by the ...

Pancreatic ductal adenocarcinoma (PDAC) is notoriously difficult to treat due to its aggressive nature and limited prognostic tools. While the traditional staging systems, such as the TNM ...

TORONTO, Dec. 05, 2024 (GLOBE NEWSWIRE) -- The Prospectors & Developers Association of Canada (PDAC) is pleased to announce that registration for the PDAC 2025 Convention, taking place March 2-5, 2025 ...

Pelareorep combined with modified FOLFIRINOX, with or without Tecentriq, shows an acceptable safety profile in metastatic PDAC patients. All patients experienced side effects, with some severe cases, ...

The annual Prospectors & Developers Association of Canada (PDAC) convention is returning this year from March 1 to 4, and it comes at a significant time for the global resource sector. Precious metals ...